Brief: Innocan Pharma Reports Success In A Pre-Clinical Trial Of A Liposomal-Cbd Injection On A Paralyzed Goat
08/05/2023 23:19
May 8 (Reuters) - Innocan Pharma Corp INNO.CD :
* INNOCAN PHARMA REPORTS SUCCESS IN A PRE-CLINICAL TRIAL OF
A
LIPOSOMAL-CBD INJECTION ON A PARALYZED GOAT
Source text for Eikon: ID:nCNW5sbdwa
Further company coverage: INNO.CD
((Reutersbriefs@thomsonreuters.com;))
Recent news on Innocan Pharma
See all newsBrief: Innocan Pharma Corp To Offer Up To 3.75 Million Units In IPO - SEC Filing
Brief: Innocan Pharma Announces Promising Results Of LPT-CBD Administered To Gottingen Minipigs
Brief: Innocan Pharma Corp - Liposomal Cbd Injection Technology Patent Allowed In Japan
Brief: Innocan Pharma Corp Now Sees U.S IPO Of 1.1 Million Units - SEC Filing
Brief: Innocan Pharma Announces Details Of Proposed Share Consolidation